Drug interactions every Indian pharmacist should watch for

Drug interactions are one of the most preventable causes of adverse events in Indian healthcare. Yet they remain common, particularly in settings where patients see multiple doctors who do not share prescription records, and where over-the-counter purchases happen without pharmacist consultation.

This guide covers the drug interactions that Indian pharmacists encounter most frequently — based on the prescribing patterns, OTC habits, and comorbidity profiles common in the Indian patient population. This is not a textbook list. It is a practical reference for the combinations you are most likely to see walk through your dispensing counter.

Warfarin: the interaction magnet

Warfarin remains widely prescribed in India for atrial fibrillation, deep vein thrombosis, and post-valve replacement patients. It is also one of the most interaction-prone drugs in clinical use.

Warfarin + NSAIDs (diclofenac, ibuprofen, aceclofenac). This is arguably the most dangerous common interaction in Indian practice. NSAIDs are prescribed liberally for musculoskeletal pain, and patients often buy them over the counter. The combination increases bleeding risk through two mechanisms: NSAIDs inhibit platelet function, and they displace warfarin from protein binding sites, increasing free warfarin levels. A patient on warfarin who takes diclofenac for knee pain for a week can end up with an INR of 8+ and a life-threatening bleed.

Warfarin + antibiotics (metronidazole, fluconazole, co-trimoxazole). Metronidazole is prescribed extremely commonly in India — for dental infections, GI infections, and amoebiasis. It inhibits warfarin metabolism, pushing the INR up. Fluconazole (commonly prescribed for fungal infections) does the same. When a patient on warfarin gets a course of metronidazole from a different doctor, the pharmacist is often the last checkpoint before a dangerous interaction occurs.

Warfarin + traditional remedies. Many Indian patients take ayurvedic or herbal supplements without informing their allopathic doctors. Ashwagandha, ginger supplements, ginkgo biloba, and even high-dose garlic capsules can alter warfarin metabolism or enhance antiplatelet effects. Always ask warfarin patients if they take any supplements or home remedies.

Metformin: watch the kidneys and the contrast

Metformin is the most prescribed antidiabetic drug in India, and for good reason. But there are two interaction scenarios that Indian pharmacists must be alert to.

Metformin + contrast dye (iodinated contrast). When a diabetic patient on metformin undergoes a CT scan or angiography with iodinated contrast, there is a risk of contrast-induced nephropathy. If kidney function drops, metformin is not cleared properly, leading to lactic acidosis — which has a mortality rate of up to 50%. The standard protocol is to stop metformin 48 hours before and 48 hours after contrast administration, and restart only after confirming normal kidney function.

The problem in practice is that the radiologist orders the scan, the patient continues metformin because nobody told them to stop, and the pharmacist never knew about the scan. If a patient mentions they are "going for a scan" or "angiography," ask about metformin.

Metformin + alcohol. Heavy alcohol consumption combined with metformin increases the risk of lactic acidosis. While moderate alcohol is generally tolerated, binge drinking — which is common in certain Indian demographics — is genuinely dangerous with metformin. This interaction is under-discussed in patient counselling.

Antihypertensives: the combinations that cause trouble

Hypertension is epidemic in India, and patients are frequently on multiple antihypertensive drugs. Some combinations work well together. Others do not.

ACE inhibitors + potassium-sparing diuretics (enalapril + spironolactone). Both raise potassium levels. The combination can cause hyperkalemia, particularly in patients with even mildly impaired renal function — which is common in elderly hypertensive patients. Monitor potassium levels regularly if this combination is prescribed.

ACE inhibitors + ARBs (enalapril + telmisartan). Dual RAAS blockade was once thought to be beneficial but has been shown to increase the risk of hyperkalemia, hypotension, and renal impairment without improving outcomes. If you see this combination on a prescription, it is worth flagging with the prescribing physician.

Amlodipine + simvastatin (high dose). Amlodipine inhibits CYP3A4, which metabolises simvastatin. When combined, simvastatin levels increase, raising the risk of rhabdomyolysis. The FDA recommends limiting simvastatin to 20 mg/day when combined with amlodipine. In India, where simvastatin 40 mg is commonly prescribed, this interaction is frequently overlooked.

Beta-blockers + verapamil/diltiazem. Both slow heart rate and conduction. The combination can cause severe bradycardia, heart block, or even asystole in susceptible patients. This is a contraindicated combination that still appears on prescriptions, particularly when a cardiologist prescribes one and a general physician prescribes the other.

The OTC problem: what patients buy without telling you

In India, OTC medicine purchases are common and largely unregulated in practice. Patients buy cough syrups, antacids, pain relievers, and antihistamines without consulting anyone. Some of these interact significantly with prescription medications.

Antacids (aluminium/magnesium hydroxide) + fluoroquinolones. Antacids chelate ciprofloxacin, levofloxacin, and other fluoroquinolones, reducing their absorption by up to 90%. A patient taking Gelusil with their ciprofloxacin is essentially not taking ciprofloxacin at all. Counsel patients to separate these by at least 2 hours.

Cough syrups containing dextromethorphan + SSRIs. Many OTC cough syrups contain dextromethorphan. Combined with SSRIs (fluoxetine, sertraline — increasingly common prescriptions in India), it can cause serotonin syndrome: agitation, hyperthermia, rapid heart rate. Patients on antidepressants should be specifically warned about this.

Omeprazole + clopidogrel. Omeprazole is India's most popular PPI, often purchased OTC for acidity. It inhibits CYP2C19, which is needed to convert clopidogrel to its active form. A cardiac patient on clopidogrel who self-medicates with omeprazole for acidity is getting reduced antiplatelet protection. Pantoprazole is the safer PPI alternative with clopidogrel.

Nimesulide. Still available in India despite being banned in many countries, nimesulide is hepatotoxic and interacts with anticoagulants, antihypertensives, and methotrexate. Patients buy it for pain relief without knowing the risks. If you are dispensing it, always check for concurrent medications.

Building a safety net

The most effective way to catch drug interactions is to have a complete picture of what the patient is taking — prescription drugs, OTC purchases, ayurvedic supplements, and home remedies. In practice, this is difficult because patients see multiple doctors and buy medicines at multiple pharmacies.

As a pharmacist, you are often the last person who sees the full medication list before the patient takes the drugs. Ask the right questions. "Are you taking any other medicines?" is not enough — patients do not consider OTC drugs or supplements as "medicines." Ask specifically: "Any pain killers? Antacids? Cough syrup? Any ayurvedic or herbal tablets? Anything for sleep?"

A good pharmacy management system with built-in drug interaction checking can flag dangerous combinations automatically at the dispensing counter. This does not replace clinical judgment, but it catches the interactions that a busy pharmacist might miss during a hectic afternoon shift.

Every interaction caught is a potential adverse event prevented. In a country where polypharmacy is common and OTC access is liberal, the pharmacist's role as a safety net has never been more important.